Ben Patterson who is working as a consultant for Inmed is from Eli Lilly & Martin Bott one of Inmed’s Directors is also from Eli Lilly. The comparisons between Inmed’s Biosynthesis process and Insulin Biosynthesis by Eli Lilly has been used strongly as comparables in publications for at least the last 2 years. So it’s safe to assume Eli Lilly is well aware of who and what Inmed Pharmaceuticals are.
In other words... it’s a logical guess/hope! I think we all realize the CMO can be anybody, but Eli Lilly’s name would give us some amazing exposure :)
Sam as other have pointed out the connection to Eli Lilly, here is a connection that seems to have gone unnoticed. Sazzad Hossain, Ph.D. Chief Scientific Officer 20+ years of academic/industry experience in drug discovery and development; and Canada’s National Research Council They are who Inmed just signed an agreement with. So to make the Eli Lilly connection is not that radical of an idea.
News 
Market Data 
Discover 
